74290-69-0 Usage
General Description
2-Amino-5-bromo-6-methylpyrazine is a chemical compound with the molecular formula C5H6BrN3. It is a brominated derivative of pyrazine, a six-membered aromatic heterocycle containing two nitrogen atoms. 2-AMINO-5-BROMO-6-METHYLPYRAZINE is commonly used as a flavoring agent and can be found in various food and beverage products. It has a strong, savory, and slightly earthy aroma, making it a popular ingredient in the food industry. Additionally, 2-amino-5-bromo-6-methylpyrazine has been studied for its potential pharmacological activities, including its anti-cancer and anti-microbial properties.
Check Digit Verification of cas no
The CAS Registry Mumber 74290-69-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,2,9 and 0 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 74290-69:
(7*7)+(6*4)+(5*2)+(4*9)+(3*0)+(2*6)+(1*9)=140
140 % 10 = 0
So 74290-69-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H6BrN3/c1-3-5(6)8-2-4(7)9-3/h2H,1H3,(H2,7,9)
74290-69-0Relevant articles and documents
ANTIDIABETIC BICYCLIC COMPOUNDS
-
, (2019/06/09)
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-co
SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALLOSTERIC MODULATORS OF GROUP II METABOTROPIC GLUTAMATE RECEPTORS
-
Page/Page column 86, (2014/01/07)
The present invention relates to the pyrazoloquinazolinone and pyrroloquinazolinone derivatives of the general formula (I), as well as pharmaceutical compositions containing them, and their use in the treatment and/or prophylaxis of conditions associated with altered glutamatergic signalling and/or functions, and/or conditions which can be affected by alteration of glutamate level or signalling in mammals, in particular their use in the treatment and/or prophylaxis of acute and chronic neurological and/or psychiatric disorders.
